Testing Aβ toxicity on primary CNS cultures using drug-screening microfluidic chips

A. Ruiz, P. Joshi, R. Mastrangelo, M. Francolini, C. Verderio, M. Matteoli

Research output: Contribution to journalArticlepeer-review


Open microscale cultures of primary central nervous system (CNS) cells have been implemented in microfluidic chips that can expose the cells to physiological fluidic shear stress conditions. Cells in the chips were exposed to differently aggregated forms of beta-amyloid (Aβ), i.e. conditions mimicking an Alzheimer's Disease environment, and treated with CNS drugs in order to assess the contribution of glial cells during pharmacological treatments. FTY720, a drug approved for the treatment of Multiple Sclerosis, was found to play a marked neuroprotective role in neuronal cultures as well as in microglia-enriched neuronal cultures, preventing neurodegeneration after cell exposure to neurotoxic oligomers of Aβ. This journal is

Original languageEnglish
Pages (from-to)2860-2866
Number of pages7
JournalLab on a Chip - Miniaturisation for Chemistry and Biology
Issue number15
Publication statusPublished - Aug 7 2014

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)
  • Bioengineering
  • Biomedical Engineering
  • Medicine(all)


Dive into the research topics of 'Testing Aβ toxicity on primary CNS cultures using drug-screening microfluidic chips'. Together they form a unique fingerprint.

Cite this